精達股份(600577.SH)擬向銅陵浦發申請授信總金額不超8.5億元
格隆匯 1 月 11日丨精達股份(600577.SH)公佈,公司於2021年1月10日召開了第七屆董事會第十六次會議,會議審議通過了《關於向上海浦東發展銀行銅陵支行申請綜合授信的議案》,具體內容如下:
為保證公司日常運營和各子公司臨時資金需求,擬向上海浦東發展銀行銅陵支行(“銅陵浦發”)申請授信總金額(時點數)本外幣摺合人民幣不超過8.5億元(包括但不限於貸款、銀行承兑匯票敞口、信用證敞口和保函等中間業務敞口以及特定權限業務額度)(具體授信額度及擔保方式最終以銀行實際批覆為準)。上述申請有效期自董事會審議通過之日起12個月之內有效,授信額度可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.